Live Chat Software

Whitepapers

Content Pack: Top Industry Content

Content Pack: Top Industry Content

For the 15th Annual Global Forum, we re-released some of the most well received industry content from 2016's event.

Take a look at our Global Forum Content Pack or request an emailed copy that includes:

  • In-depth report on "Standardization and Risk Management in the Cold Chain"
  • Best Practice Guidebook for "Packaging Design & Qualification in Temperature Controlled Logistics"
  • Global Mastery eBook featuring interviews with Eli Lilly, Amgen, McKesson, Novartis LatAm and many more

Email enquiry@iqpc.com to request an emailed copy.

Whitepaper: Insights from the Experts

Whitepaper: Insights from the Experts

It's an innovative time in the industry as new technologies are changing the supply chain and business are trying to find new ways to get their products where they need to be faster, more efficiently while saving money. See what executives from Merck, Amgen, Zogenix, Marketing Association, Eli Lilly, GlaxoSmithKline and more are saying about the current state of the industry, future trends, and what they look forward to most about the Global Forum.
End-to-End Supply Chain Visibility

End-to-End Supply Chain Visibility

The Associate Director of Supply Chain Management at Merck gives us deeper dive into end-to-end supply chain visibility in this white paper.
CRT Requirement in Pharma Distribution

CRT Requirement in Pharma Distribution

Pelican BioThermal was a participating sponsor of the 15th Annual Global Forum. Read their white paper here.
Moving Towards Collaboration Whitepaper

Moving Towards Collaboration Whitepaper

Collaboration has long been considered an effective approach and is employed by many highfunctioning organizations. In business and in communities, the strategic value of aligning yourself with other groups that have a shared vision, where each collaborator brings something to the table and is willing to work together to get there is now seen. Collaboration between different groups - within and outside the enterprise – makes for a changed dynamic. It is a commonly held view that stakeholders in collaboration are at their best, fully invested and engaged, even if conflict situations arise. This whitepaper dives into how collaboration is effective for the pharmaceutical supply chain industry.
DSCSA’s Impact on Global Supply Chain

DSCSA’s Impact on Global Supply Chain

  • Examine the full scope of DSCSA requirements and top international serialization deadlines that are looming How can logistics professionals support serialization teams past the 2017 deadline
  • What application does serialization technology have for temperature monitoring? Can they work in tandem?
  • Predicting how a post-serialized world will affect the pharma supply chain

Presentation by Matt Sample Sr. Director, Secure Supply Chain AmerisourceBergen Corporation

Clinical Trial Supply 2018 Report: The Quest To Shrink Wastage Levels

Clinical Trial Supply 2018 Report: The Quest To Shrink Wastage Levels

In meeting the growth ahead for clinical trials there must be a focus on efficiency as their supply already suffers from major issues with wastage levels. This is lack of control is problematic with the rising public scrutiny on spending by pharmaceutical companies.

Forecasting and demand planning

When sites are under supplied, sponsors may be forced to halt enrolment or even freeze patient treatments. This could have a large influence on the outcomes of a trial. Due to a range of factors, study design, patient enrolment, quantity of sites, site location, that can suddenly change the level of supplies needed for a trial to run, supply managers reduce the risk of stock outs by supplying a surplus of medicine. This in many cases spills over to become overage – when the investigational medicines have to be wasted at the end of a trial or hit their expiry dates before consumption.

From Production to Patients: Optimizing the Last Mile of the Supply Chain

From Production to Patients: Optimizing the Last Mile of the Supply Chain

Though life sciences companies see value across the full supply chain, it’s the last mile that matters the most to the customer. When customers can’t get what they want when they want it due to product loss, theft, spoilage, counterfeiting or other disruptions, it can be incredibly damaging to a company’s brand and bottom line.

With this in mind, we surveyed 150+ pharma logistics leaders to learn more about the key challenges, solutions and trends impacting the last mile of the life sciences supply chain. Highlights include:

  • Analysis of what causes the most last mile disruptions and how firms are addressing these issues
  • An overview of our respondents top strategic priorities
  • Facts & figures that outline where cold chain leaders are looking to invest on 2018 & 2019


From Production to Patients: An In-Depth Report on Optimizing the Last Mile of the Life Sciences Supply Chain

From Production to Patients: An In-Depth Report on Optimizing the Last Mile of the Life Sciences Supply Chain

How are leading-edge pharma firms optimizing the last mile of the supply chain? Find out in our most recent report!

Pharma Logistics Compliance 2018 Report

Pharma Logistics Compliance 2018 Report

This whitepapers covers the latest pharmaceutical logistics regulatory developments around the globe related to FMD, MHRA, ICH Q12, PACMP, GMP, DSCSA and more! Designed specifically to keep you up to date with key developments that we believe with shape the compliance agenda over the next year, key developments that you will need to tune in for! Highlights include:

  • GMP inspections international collaboration efforts
  • Supply Chain Security and Traceability – GPS
  • EMA regulations
  • Points to remember for your next GDP inspection
  • The latest on Human Drug Compounding Outsourcing Facilities regulations
  • An analysis of ICH Q12 concepts
  • The cost of Brexit and the road forward
  • An overview of EU's recently published report detailing the implementation of the Falsified Medicines Directive (FMD)

Plus! Commentary by 2018 Cold Chain Global Forum speakers:

  • Rafik Bishara, Ph.D, former Director QKMTS, Eli Lilly and Company
  • Ajay Pazhayattil, Former Associate Director, TOPV Apotex Inc.


Change & Collaboration in Pharma Logistics

Change & Collaboration in Pharma Logistics

Pharma is one of the most conservative industries –namely due to the fact that its products are high risk – very influential to the health, well-being and survival of their consumers. Regulations must be met to ensure that medicine quality and patient safety is protected. Therefore any changes, be it to product or process, need to be controlled to ensure that these vital elements are not in anyway jeopardized.

In the latest article by Pharma IQ,we uncover:

  • How to identify and overcome common obstacles to change management in pharma
  • Establishing standardized packaging vendor qualification requirements
  • Why collaboration and intelligence sharing between drug manufacturers could drastically improve the landscape for the general market. 
  • And more!

Features insights by:

  • Guy Hoskens, Clinical Supply Chain Logistics Expert, Janssen, Pharmaceutical
  • Tonino Antonetti, Executive Director, Regulatory Affairs, Quality Management, Safety & Health, Roche Diagnostics 
  • Craig Vermeyen, Senior Manager, Packaging Engineer, Kite Pharma 


To receive a copy of this article via email, write us at enquiry@iqpc.com with "16CCGF Content Request: Change & Collaboration in Pharma Logistics" in the subject line.

Blockchain Adoption in Pharma Supply

Blockchain Adoption in Pharma Supply

Experts have asserted that despite recent developments, pharmaceutical supply chains are still far from reaching their full technological potential. However, Blockchain holds significant promise to advance the digital strength of medicine supply. In this whitepaper, we explore:

  • What is blockchain and how can it be applied to cold chain?
  • Who in life sciences is currently using blockchain and for what?
  • How will the emergence of blockchain impact the industry over the next decade?

Plus! We provide an overview of potential use cases for block chain such as:

  • Leveraging R&D data for collaborative research
  • Dynamic pricing managed for raw materials
  • Compliance and quality tracking
  • Pharmacovigilance reporting
  • Temperature control
  • Temperature monitoring and control